Steven Yatomi-Clarke
Vorstandsvorsitzender bei PRESCIENT THERAPEUTICS LIMITED
Vermögen: 378 056 $ am 30.04.2024
Profil
Steven Yatomi-Clarke is currently the Chief Executive Officer, MD & Executive Director at Prescient Therapeutics Ltd.
He started this position in 2016.
Previously, he worked as the Director-Corporate Finance at Patersons Securities Ltd.
He has an undergraduate degree from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.05.2023 | 11 195 017 ( 1,39% ) | 378 056 $ | 30.04.2024 |
Aktive Positionen von Steven Yatomi-Clarke
Unternehmen | Position | Beginn |
---|---|---|
PRESCIENT THERAPEUTICS LIMITED | Vorstandsvorsitzender | 15.02.2016 |
Ehemalige bekannte Positionen von Steven Yatomi-Clarke
Unternehmen | Position | Ende |
---|---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Corporate Officer/Principal | - |
Ausbildung von Steven Yatomi-Clarke
University of Melbourne | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PRESCIENT THERAPEUTICS LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Finance |